用于脑肿瘤治疗的药物递送系统。
Drug delivery systems for brain tumor therapy.
作者信息
Rautioa Jarkko, Chikhale Prashant J
机构信息
Department of Pharmaceutical Chemistry, University of Kuopio, P.O.Box 1627, FIN-70211 Kuopio, Finland.
出版信息
Curr Pharm Des. 2004;10(12):1341-53. doi: 10.2174/1381612043384916.
Brain tumors are one of the most lethal forms of cancer. They are extremely difficult to treat. Although, the rate of brain tumor incidence is relatively low, the field clearly lacks therapeutic strategies capable of overcoming barriers for effective delivery of drugs to brain tumors. Clinical failure of many potentially effective therapeutics for the treatment of brain tumors is usually not due to a lack of drug potency, but rather can be attributed to shortcomings in the methods by which a drug is delivered to the brain and into brain tumors. In response to the lack of efficacy of conventional drug delivery methods, extensive efforts have been made to develop novel strategies to overcome the obstacles for brain tumor drug delivery. The challenge is to design therapeutic strategies that deliver drugs to brain tumors in a safe and effective manner. This review provides some insight into several potential techniques that have been developed to improve drug delivery to brain tumors, and it should be helpful to clinicians and research scientists as well.
脑肿瘤是最致命的癌症形式之一。它们极难治疗。尽管脑肿瘤的发病率相对较低,但该领域显然缺乏能够克服将药物有效递送至脑肿瘤的障碍的治疗策略。许多用于治疗脑肿瘤的潜在有效疗法在临床上的失败通常不是由于药物效力不足,而是可归因于药物递送至脑和脑肿瘤的方法存在缺陷。针对传统药物递送方法缺乏疗效的问题,人们已做出广泛努力来开发新策略以克服脑肿瘤药物递送的障碍。挑战在于设计以安全有效的方式将药物递送至脑肿瘤的治疗策略。本综述对已开发的几种改善药物递送至脑肿瘤的潜在技术提供了一些见解,对临床医生和科研人员也应有所帮助。